Response of a human colon adenocarcinoma (DLD-1) to X irradiation and mitomycin C in vivo

Int J Radiat Oncol Biol Phys. 1983 Aug;9(8):1209-12. doi: 10.1016/0360-3016(83)90182-7.

Abstract

Mice hosting a heterogeneous human colon xenograft tumor produced by subcutaneous injection of the DLD-1 tumor cell line were treated either with x irradiation alone, with mitomycin C alone (4 mg/kg), or with x irradiation given two hours after intraperitoneal injection of mitomycin C (4 mg/kg). Radiation alone produced a dose dependent delay in the time needed for tumors to regrow to twice their size at the time of irradiation, and in the mice receiving mitomycin C plus x irradiation, an additional growth delay equivalent to that produced by 3-3.5 Gy of X rays was seen at all X ray dose levels. As the DLD-1 tumor xenografts do not appear to possess a significant hypoxic fraction, we conclude that the two agents are acting in a simple additive cytotoxic manner by the killing of oxic tumor cells.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenocarcinoma / drug therapy
  • Adenocarcinoma / radiotherapy
  • Adenocarcinoma / therapy*
  • Animals
  • Antibiotics, Antineoplastic / administration & dosage*
  • Colonic Neoplasms / drug therapy
  • Colonic Neoplasms / radiotherapy
  • Colonic Neoplasms / therapy*
  • Humans
  • Mice
  • Mice, Nude
  • Mitomycin
  • Mitomycins / administration & dosage*
  • Neoplasm Transplantation
  • Neoplasms, Experimental / drug therapy
  • Neoplasms, Experimental / radiotherapy
  • Transplantation, Heterologous

Substances

  • Antibiotics, Antineoplastic
  • Mitomycins
  • Mitomycin